老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

神經分泌生物科學

118.70
-1.8650-1.55%
成交量：18.44萬
成交額：2,198.42萬
市值：117.47億
市盈率：40.14
高：120.10
開：119.67
低：118.39
收：120.56
資料載入中...
總覽公司新聞公告
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/04

重要事件披露

8-K - Current report
2021/02/02

重要事件披露

8-K - Current report
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

重要事件披露

8-K - Current report
2020/11/24

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/09/10

重要事件披露

8-K - Current report
2020/08/28

重要事件披露

8-K - Current report
2020/08/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多